| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/08/2004 | CN1526380A Metoprolol dripping pills and the prepn process thereof |
| 09/08/2004 | CN1526379A Sibutramine hydrochloride dripping pill and its prepn |
| 09/08/2004 | CN1526377A Total emodin anthraquinone granule and its prepn and the prepn of dispersive Sanhuang tablet |
| 09/08/2004 | CN1526376A Two-phase hard capsule and its application |
| 09/08/2004 | CN1526375A Effervescent American ginseng tablet and its production process |
| 09/08/2004 | CN1526374A Compounding prepn of Chinese medicine tablet coating |
| 09/08/2004 | CN1526373A Prepn of foamed aerosol medicine and its administrating device |
| 09/08/2004 | CN1526372A Long-acting injection capable of inhibiting abrupt release effect |
| 09/08/2004 | CN1166191C Method for transmitting & receiving coded data and transmitter and receiver |
| 09/08/2004 | CN1165345C Prucalopride oral solution and preparing method thereof |
| 09/08/2004 | CN1165341C Liquid gonadotropin containing formulations |
| 09/08/2004 | CN1165339C Pharmaceutical compositions of erythropoietin |
| 09/08/2004 | CN1165335C Compound preparation for curing diarrhea |
| 09/08/2004 | CN1165328C New prepn process of Lideri ganula as one traditional Mongoliam medicine |
| 09/08/2004 | CN1165326C New prepn process of Zhuanglong granula as one traditional Mongolian medicine |
| 09/08/2004 | CN1165325C New prepn process of Manu as one traditional Mongolian medicine |
| 09/08/2004 | CN1165316C Method for preparing nano level pearli powder |
| 09/08/2004 | CN1165313C Slowly released clamycin capsule |
| 09/08/2004 | CN1165311C Slow-releasing coposition of estrogen medicine and its preparing process |
| 09/08/2004 | CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450 |
| 09/08/2004 | CN1165309C Stable compositions comprising levosimendan and alginic acid |
| 09/08/2004 | CN1165308C Compositions and method for reducing respiratory depression and attendant side effect of mu opioid compounds |
| 09/08/2004 | CN1165307C Controlled release oxycodone compositions |
| 09/08/2004 | CN1165305C Lyophilized composition of nimodipine |
| 09/08/2004 | CN1165304C Nimudipin undertongue spraying agent |
| 09/08/2004 | CN1165300C Parenteral paclitaxel stable non-toxic formulation |
| 09/08/2004 | CN1165299C Composition for treatment of psoriasis |
| 09/08/2004 | CN1165297C Composition for transdermal administration |
| 09/08/2004 | CN1165296C Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as coating agent, binding agent and/or film-forming auxiliary agent |
| 09/08/2004 | CN1165295C Controlled-release compositions of betahistine |
| 09/08/2004 | CN1165294C Controlled release preparations having multi-layer structure |
| 09/08/2004 | CN1165293C New oral formulation for 5-HT4 agonists or antagonists |
| 09/08/2004 | CN1165292C Composition comprising liquid absorbed on support based on precipitate silica |
| 09/08/2004 | CN1165291C Anti-fungus composition with improved biological utilization rate |
| 09/08/2004 | CN1165290C New medicine release system-liposolubility medicinal preparation |
| 09/08/2004 | CN1165289C Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 09/08/2004 | CN1165224C Method for preparing suspended pesticides concentrates |
| 09/07/2004 | US6787572 Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies |
| 09/07/2004 | US6787568 Antibiotic/analgesic formulation and a method of making this formulation |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 09/07/2004 | US6787529 Synergistic mixture of vitamin d and corticosteroids; skin disorders |
| 09/07/2004 | US6787342 Paste formulations |
| 09/07/2004 | US6787165 Viricides, bactericides |
| 09/07/2004 | US6787160 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 09/07/2004 | US6787157 Multiphase active ingredient-containing formulations |
| 09/07/2004 | US6787156 Controlled release composition |
| 09/07/2004 | US6787155 Delay release formulation of a non-steroidal anti-inflammatory drug (nsaid) and a mixture containing a prostaqlandin and one or more excipients; for therapy of osteoarthritis or rheumatoid arthritis |
| 09/07/2004 | US6787153 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 09/07/2004 | US6787152 Balancing the molecular properties (van der waals forces and dipole moments) of all the components against those of all the components plus the particular active agent. |
| 09/07/2004 | US6787132 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/07/2004 | US6787131 Method for enhancing integrity of epithelium using retinoic acid |
| 09/07/2004 | US6787090 Method of producing structures using centrifugal forces |
| 09/07/2004 | US6786929 Flexible vascular inducing implants and methods |
| 09/07/2004 | CA2421316A1 Enhanced delivery of sphingolipids |
| 09/07/2004 | CA2337015C Excipient |
| 09/07/2004 | CA2315726C Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby |
| 09/07/2004 | CA2222642C Micro-encapsulated lactobacilli for medical applications |
| 09/07/2004 | CA2102777C Novel compositions based on taxane class derivatives |
| 09/05/2004 | CA2459519A1 Solid, accurately dosable pharmaceutical presentations for individual dispensing from dosing devices and methods thereof |
| 09/05/2004 | CA2428711A1 Formulations and methods of delivery of intact tocopheryl succinate to humans |
| 09/03/2004 | CA2456410A1 Stabilised pharmaceutical composition comprising an extented release non-steroidal anti-inflammatory agent and an immediate release prostaglandin |
| 09/02/2004 | WO2004074791A2 Method and device for generating mists and medical uses thereof |
| 09/02/2004 | WO2004074509A2 Reversible attachment of a membrane active polymer to a polynucleotide |
| 09/02/2004 | WO2004074314A2 Chistosan-microparticles for ifn gene delivery |
| 09/02/2004 | WO2004074215A1 Process for preparation of clopidogrel, its salts and pharmaceutical compositions |
| 09/02/2004 | WO2004074190A1 Magnetic fluid treatment device and uses thereof |
| 09/02/2004 | WO2004074171A1 Method for introducing functional material into organic nanotube |
| 09/02/2004 | WO2004073827A1 Process for the production of particles |
| 09/02/2004 | WO2004073773A1 Apparatus and method for tissue rinse |
| 09/02/2004 | WO2004073768A2 Occlusion resistant hydrocephalic shunt |
| 09/02/2004 | WO2004073765A2 Drug delivery device and syringe for filling the same |
| 09/02/2004 | WO2004073749A1 Dispersant for sustained release preparations |
| 09/02/2004 | WO2004073748A1 Aqueous suspension medicine |
| 09/02/2004 | WO2004073747A1 Orally administrable pharmaceutical compositions and methods for preventing food-dr ug interaction |
| 09/02/2004 | WO2004073746A1 Use of 2-hydroxymethyltetrahydropyran as excipient in a pharmaceutical or cosmetic composition |
| 09/02/2004 | WO2004073745A1 Salicylic acid derivative as efficacy enhancer and method |
| 09/02/2004 | WO2004073744A1 Seamless capsule |
| 09/02/2004 | WO2004073743A2 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions |
| 09/02/2004 | WO2004073738A2 Composition to be administered to a living being and method for marking agents |
| 09/02/2004 | WO2004073735A1 Improved anthrax vaccines and delivery methods |
| 09/02/2004 | WO2004073729A1 Compositions for nasal administration of drug |
| 09/02/2004 | WO2004073723A1 Medical drug containing fine particle of noble metal |
| 09/02/2004 | WO2004073722A1 Superoxide anion decomposing agent |
| 09/02/2004 | WO2004073720A1 Use of pvp-iodine liposomes for treatment of acne |
| 09/02/2004 | WO2004073718A1 Therapeutic agent for hemorrhoidal disease |
| 09/02/2004 | WO2004073707A1 Topical composition containing alkyl gallate or alkyl hydroxybenzoate or phenol alkyloxy as agent against acne |
| 09/02/2004 | WO2004073702A1 Buccal cavity treatment composition and corresponding uses thereof |
| 09/02/2004 | WO2004073697A1 Alginate foam compositions |
| 09/02/2004 | WO2004073696A1 Uv stable transdermal therapeutic plaster |
| 09/02/2004 | WO2004073695A1 Therapeutic system comprising amoxicillin and clavulanic acid |
| 09/02/2004 | WO2004073694A1 Method to treat chronic heart failure and/or elevated cholesterol levels |
| 09/02/2004 | WO2004073693A1 Soft capsule containing cyclosporine and it's manufacturing process |
| 09/02/2004 | WO2004073692A1 Hard capsule of hardly water-soluble drug |
| 09/02/2004 | WO2004073691A1 Chewing gum in the form of multi-layer tablets |
| 09/02/2004 | WO2004073690A1 Self-expanding device for the gastrointestinal or urogenital area |
| 09/02/2004 | WO2004073689A1 Use of a silica or silica derivative as a sorption material |
| 09/02/2004 | WO2004073688A1 Drug delivery from embolic agents |
| 09/02/2004 | WO2004073687A1 Method for preparation of an agglomerate using melt agglomeration |
| 09/02/2004 | WO2004073686A2 Menthol solutions of drugs |
| 09/02/2004 | WO2004073685A1 Dexamethasone-containing formulations for oral administration as well the process for manufacturing required therefor |